Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes
Josephine M. Forbes(Translational Research Institute), Per‐Henrik Groop(University of Helsinki), Hiroshi Yamamoto(Komatsu University), Carol Forsblom(University of Helsinki), Jenny Söderlund(Helsinki University Hospital), Sofianos Andrikopoulos(The University of Melbourne), Felicia Y. T. Yap(Baker Heart and Diabetes Institute), Melinda T. Coughlan(Baker Heart and Diabetes Institute), Angelika Bierhaus(Heidelberg University), Jorma Ilonen(University of Turku), Shane T. Grey(UNSW Sydney), Olli Simell(Turku University Hospital), Maija Wessman(University of Helsinki), K. C. Sourris(Baker Heart and Diabetes Institute), M. E. Cooper(Australian Regenerative Medicine Institute), Mikael Knip(Åbo Akademi University), Robyn M. Slattery(Monash University), Riitta Veijola(Diabetes Tutkimussaatio)
Cited by 48
Related Papers
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
|Cell Host & Microbe|2015|1.2k
Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability
|Science Translational Medicine|2016|1.1k
Toward defining the autoimmune microbiome for type 1 diabetes
|The ISME Journal|2010|814